Japan, Jan. 30 -- SHANGHAI VITALGEN BIOPHARMA CO LTD has got intellectual property rights for 'RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING BIETTI CRYSTALLINE DYSTROPHY.' Other related details are as follows:
Application Number: JP,2025-043347
Category (FI): A61K35/76,C12N15/63@Z,C12N15/12,C12N15/11@Z,A61P27/02,A61K48/00,C12N7/01,C12N15/864,100@Z
Stage: Grant (IP right granted following substantive examination.)
Filing Date: March 18, 2025
Publication Date: June 17, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....